{"name":"DALY 2: the next treatment option for DLBCL may start her","short_name":"DALY 2","description":"DALY 2 clinical trials for the investigation of the new investigational medicinal product, zamtocabtagene autoleucel, a personalized CAR T- cell therapy for patients suffering from diffuse large B cell lymphoma (DLBCL).","start_url":"/","lang":"en","background_color":"#3c1192","theme_color":"#3c1192","display":"standalone","icons":[{"src":"favicons/icon-48x48.png?v=3b78984f4983c641bbd20caf142af862","sizes":"48x48","type":"image/png"},{"src":"favicons/icon-72x72.png?v=3b78984f4983c641bbd20caf142af862","sizes":"72x72","type":"image/png"},{"src":"favicons/icon-96x96.png?v=3b78984f4983c641bbd20caf142af862","sizes":"96x96","type":"image/png"},{"src":"favicons/icon-144x144.png?v=3b78984f4983c641bbd20caf142af862","sizes":"144x144","type":"image/png"},{"src":"favicons/icon-192x192.png?v=3b78984f4983c641bbd20caf142af862","sizes":"192x192","type":"image/png"},{"src":"favicons/icon-256x256.png?v=3b78984f4983c641bbd20caf142af862","sizes":"256x256","type":"image/png"},{"src":"favicons/icon-384x384.png?v=3b78984f4983c641bbd20caf142af862","sizes":"384x384","type":"image/png"},{"src":"favicons/icon-512x512.png?v=3b78984f4983c641bbd20caf142af862","sizes":"512x512","type":"image/png"}],"cacheDigest":"3b78984f4983c641bbd20caf142af862"}